Statistical validation of reagent lot change in the clinical chemistry laboratory can confer insights on good clinical laboratory practice

被引:11
作者
Cho, Min-Chul [1 ,2 ]
Kim, So Young [3 ,4 ]
Jeong, Tae-Dong [5 ,6 ]
Lee, Woochang [5 ,6 ]
Chun, Sail [5 ,6 ]
Min, Won-Ki [5 ,6 ]
机构
[1] Gyeongsang Natl Univ Hosp, Dept Lab Med, Jinju, South Korea
[2] Gyeongsang Natl Univ, Sch Med, Jinju, South Korea
[3] Catholic Univ Korea, Dept Lab Med, Coll Med, Seoul, South Korea
[4] St Pauls Hosp, Seoul, South Korea
[5] Univ Ulsan, Dept Lab Med, Coll Med, Seoul 138736, South Korea
[6] Asan Med Ctr, Seoul 138736, South Korea
关键词
Quality assurance and control; laboratory methods; PROFICIENCY TESTING MATERIAL; FRESH-FROZEN SERUM; AMERICAN-PATHOLOGISTS SURVEYS; OF-THE-ART; INTERLABORATORY HARMONIZATION; COMMUTABILITY; ACCURACY; QUALITY; VERIFICATION; TRUENESS;
D O I
10.1177/0004563214520749
中图分类号
R446 [实验室诊断]; R-33 [实验医学、医学实验];
学科分类号
1001 ;
摘要
Verification of new lot reagent's suitability is necessary to ensure that results for patients' samples are consistent before and after reagent lot changes. A typical procedure is to measure results of some patients' samples along with quality control (QC) materials. In this study, the results of patients' samples and QC materials in reagent lot changes were analysed. In addition, the opinion regarding QC target range adjustment along with reagent lot changes was proposed. Patients' sample and QC material results of 360 reagent lot change events involving 61 analytes and eight instrument platforms were analysed. The between-lot differences for the patients' samples ((P)) and the QC materials ((QC)) were tested by Mann-Whitney U tests. The size of the between-lot differences in the QC data was calculated as multiples of standard deviation (SD). The (P) and (QC) values only differed significantly in 7.8% of the reagent lot change events. This frequency was not affected by the assay principle or the QC material source. One SD was proposed for the cutoff for maintaining pre-existing target range after reagent lot change. While non-commutable QC material results were infrequent in the present study, our data confirmed that QC materials have limited usefulness when assessing new reagent lots. Also a 1 SD standard for establishing a new QC target range after reagent lot change event was proposed.
引用
收藏
页码:688 / 694
页数:7
相关论文
共 18 条
[1]  
[Anonymous], CHEM TOX CHECKL
[2]   Placental alkaline phosphatase isoenzyme in quality control materials may be a source of variability in alkaline phosphatase activity [J].
Bae, Eunsin ;
Chung, Hee-Jung ;
Kim, Sollip ;
Lee, Woochang ;
Chun, Sail ;
Min, Won-Ki .
CLINICAL BIOCHEMISTRY, 2011, 44 (2-3) :251-253
[3]  
Bock JL, 2005, ARCH PATHOL LAB MED, V129, P323
[4]  
Cattozzo G, 2001, CLIN CHEM, V47, P2108
[5]  
ECKFELDT JH, 1993, ARCH PATHOL LAB MED, V117, P381
[6]   Impact of reference materials on accuracy in clinical chemistry [J].
Franzini, C ;
Ceriotti, F .
CLINICAL BIOCHEMISTRY, 1998, 31 (06) :449-457
[7]  
Miller WG, 2008, ARCH PATHOL LAB MED, V132, P838, DOI 10.1043/1543-2165(2008)132[838:SOTAIT]2.0.CO
[8]  
2
[9]   Commutability Limitations Influence Quality Control Results with Different Reagent Lots [J].
Miller, W. Greg ;
Erek, Aybala ;
Cunningham, Tina D. ;
Oladipo, Olajumoke ;
Scott, Mitchell G. ;
Johnson, Robert E. .
CLINICAL CHEMISTRY, 2011, 57 (01) :76-83
[10]   Why commutability matters [J].
Miller, WG ;
Myers, GL ;
Rej, R .
CLINICAL CHEMISTRY, 2006, 52 (04) :553-554